Former Pfizer employee charged with insider trading on unreleased Covid pill data

The DOJ said the former employee and his close friend sold their Pfizer call options at “significant profits” totaling more than $350,000.

Previous post Little-known NJ baby retailer tentatively wins rights to Buy Buy Baby’s IP
Next post Southwest pilots’ union lays groundwork for potential strike with labor talks at an impasse